Apellis Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 Enero 2024 - 6:00AM
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced
that the company will present at the 42nd Annual J.P. Morgan
Healthcare Conference on Monday, January 8, 2024, at 9:45 a.m. PT.
The event will be available via a live webcast from the “Events
and Presentations” page of the “Investors and Media” section of the
company’s website. A replay of the webcast will be available for
approximately 30 days following the event.
About ApellisApellis Pharmaceuticals, Inc. is a
global biopharmaceutical company that combines courageous science
and compassion to develop life-changing therapies for some of the
most challenging diseases patients face. We ushered in the first
new class of complement medicine in 15 years and now have two
approved medicines targeting C3. These include the first and only
therapy for geographic atrophy, a leading cause of blindness around
the world. We believe we have only begun to unlock the potential of
targeting C3 across serious retinal, rare, and neurological
diseases. For more information, please visit
http://apellis.com or follow us
on Twitter and LinkedIn.
Investor Contact: Meredith
Kaya meredith.kaya@apellis.com617.599.8178
Apellis Pharmaceuticals (NASDAQ:APLS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Apellis Pharmaceuticals (NASDAQ:APLS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024